Dados B3 › TCSA3 × RADL3
TCSA3 × RADL3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | TCSA3 | RADL3 | year |
|---|---|---|---|
| ROE | -30.1% | 18.9% | 2025 |
| ROIC | -2.7%! | 24.8% | 2025 |
| ROA | -7.9% | 5.5% | 2025 |
| Gross margin | -16.1% | 29.3% | 2025 |
| EBIT margin | -16.4% | 6.2% | 2025 |
| Net margin | -46.7% | 2.9% | 2025 |
| Net debt/EBITDA | 10.78x | 0.56x | 2022 |
| Current ratio | 1.44x | 1.46x | 2025 |
| Revenue growth (1y) | -54.4% | 13.8% | 2025 |
| Revenue growth (5y CAGR) | 3.5% | 17.1% | 2025 |
| Piotroski F-Score | 5/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | TCSA3 | RADL3 | year |
|---|---|---|---|
| P/E | -0.97x | 32.24x | 2025 |
| P/B | 0.34x | 5.71x | 2025 |
| EV/EBITDA | — | 9.37x | 2025 |
| FCF yield | 10.5% | 2.5% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:46 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:46 UTC. If this does not match /saude, you are reading a cached copy.